ERBB2 and breast cancer: The identity and possible roles of miRNA dysregulated in specific subtypes of breast cancer, including HER2+ [261,262], TNBC [263,264,265], and endocrine-resistant breast cancer [16,52,54,59,60] have been reviewed.